Abstract
Β-Thalassemia, which is caused by a decrease in the production of β-globin chains, affects multiple organs and is associated with considerable morbidity and mortality. Lifelong care is required, and the costs of proper treatment are substantial. This review discusses current approaches to the management of β-thalassemia.
Citation impact
937
total citations
- FWCI
- 13.09
- Percentile
- 100%
- References
- 89
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Thalassemia
- Intensive care medicine
- Pediatrics
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.